nich player global footprint initi
australian healthcar firm well posit protective-barri maker ansel
leverag macro environ hearing-impl maker cochlear qualiti
franchis expens on-going competit advantag plasma
product ramsay medium-term growth profil look histor level
final like sonic franchis like reimburs cut
australian healthcar firm oper global context gener
larg player nich oligopoli industri oper requir high
level intellectu properti make tough proposit new entrant
larger australian healthcar compani sound reput among medic
profession patient age popul particularli asia pacif
central develop healthcar stori australian market anoth
potenti leg growth local player
healthcar research compani evaluatepharma forecast
annual spend medicin reach on-going growth
forecast due novel therapi address key unmet need well
increas access medicin global equat compound-annual-growth-rate world-wide
prescript drug sale period accord evaluatepharma
evaluatemedtech forecast global med-tech industri expect grow
per year compound-annual-growth-rate culmin global sale
number grow million nearli billion
increas develop countri improv life
expect chang major health threat face global popul
infecti parasit diseas mostli affect live infant children
noncommunic typic adult disord heart diseas cancer
diabet also reflect chang lifestyl diet develop tune
societ wealth
australia attract market rel low level healthcar expenditur
percentag low averag growth rate total healthcar spend
per capita absolut amount growth need rise line age
figur recommend price target
jefferi estim iress note price cob octob
us bn
med-tech sale volum
aihw health expenditur databas
aust bureau statist
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
companybloomberg coderecommendationcurr price price upside/downsid price-to-earnings ev/ebitda ansellann carerhc careshl excl gener orphangrowth pcp prescript sale volumeworldwid med-tech sale volum bn compani
summari chang
pleas see import disclosur inform page report
ann industri divis suppli
auto metal fabric oil ga
industri whilst healthcar divis
suppli medic sector
implant baha bone
compon part sell
product global basi
ramsay largest private-hospit
oper australia
sonic healthcar one world
annual global spend medicin
reach nearli accord
evaluatepharma
compani report
ann industri divis suppli auto metal fabric oil ga industri
whilst healthcar divis suppli medic sector evid global
recoveri continu ansel could see solid revenu margin growth initi
coverag hold recommend
manufactur suppli cochlear implant ci hybrid electro-acoust
implant baha bone conduct implant qualiti global franchis
establish track record howev stock cheap forecast level growth
compar global compar initi hold rate target
separ human plasma compon part sell product global
basi industri continu grow high singl digit persist given
under-penetrated market competit advantag highest margin per
litr plasma process lowest cost product plasma-collect industri
face increas regul entri barrier mount initi buy
target
ramsay largest private-hospit oper australia also oper
uk franc itali nordic region malaysia indonesia compani
australian privat hospit bed give market power negoti
sonic healthcar one world largest clinic lab compani provid
laboratori radiolog servic medic practition hospit commun health
servic collect patient
global pharmaceut medic devic healthcar servic growth
continu
annual global spend medicin reach nearli accord
evaluatepharma growth like due novel therapi address key unmet
need well increas access medicin global equat
compound-annual-growth-rate world-wide prescript drug sale period evaluatepharma
estim us spent averag per person healthcar
evaluatepharma estim orphan drug sector expect outperform
broader pharmaceut market almost doubl size peak
account prescript sale highlight
industri continu move address small group neglect patient high
unmet need benefit tradit reduc payer scrutini orphan drug
well regulatori financi incent sell number orphan drug
pleas see import disclosur inform page report
evaluatepharma believ drug affordability/access dynam led
pressur payer includ usa increasingli act
limit prescrib option drug provid proven real-world valu continu
trend pharmaceut industri respons pressur ensur
develop value-bas price reimburs approach de-risk
healthcar budget clinic program reflect demand payer
calcul rel attract healthcar market
oecd nation assum oecd nation popul get older
approxim rate age popul need test
treatment believ attract market one like
rel larger spend market thing equal henc
attract market one current rel low spend healthcar
percentag annual growth expenditur current low
increas near-to-medium term adequ care age popul
output seen follow figur
pleas see import disclosur inform page report
 spend us bn growth pcp rh us bn figur attract healthcar market oecd nation
evaluatemedtech forecast global med-tech industri expect grow
per year compound-annual-growth-rate culmin global sale
term devic evaluatemedtech state increas market
penetr medic devic emerg countri posit impact medic
devic market devic offer high oper margin across variou industri
subsector enclos world-wide prescript med-tech sale volum
pleas see import disclosur inform page report
australiaaustriabelgiumcanadachileczech republicdenmarkestoniafinlandfrancegermanygreecehungaryicelandirelandisraelitalyjapankorealatvialithuanialuxembourgmexiconetherlandsnew zealandnorwaypolandportugalslovak republicsloveniaspainswedenswitzerlandturkeyunit kingdomunit statesoecd expenditur percentag growthrat expenditur health per capita attractiveless attract figur world-wide prescipt drug med-tech sale volum
addit larg grow increasingli wealthi middl class emerg
countri will pay high-qual medic devic govern
manag deliv past leverag low manufactur labor cost
number new drug approv continu increas annual basi
pleas see import disclosur inform page report
term clinic lab report data forecast global clinic laboratori
market project grow compound-annual-growth-rate reach
increas awar regard time diagnosi diseas particularli
impact age popul like boost growth market regulatori
norm impos govern across globe scarciti skill certifi
profession may creat hindranc growth market upcom year
world organis forecast number peopl age older
grow million nearli billion greatest rise
develop countri remark improv life expect past
year contribut shift lead caus diseas death
start centuri infecti parasit diseas mostli claim infant
children live major health threat noncommunic diseas
commonli affect adult older peopl greatest burden chronic
disord heart diseas cancer diabet reflect chang lifestyl
diet well age
potenti econom societ cost noncommunic diseas rise
sharpli age abil affect econom growth analysi
low- middle-incom countri estim econom loss heart diseas
stroke diabet place would total
forecast number peopl
age older grow
nearli
pleas see import disclosur inform page report
figur pharma spend geographi
figur pharma spend geographi
age take place alongsid
broad social trend affect older
gener children young adult grew poverti ill health
develop countri enter old age come decad potenti
increas health burden older popul countri continu
declin death rate among older peopl proport age older rise
quickli peopl live past
age take place alongsid broad social trend affect older peopl
economi globalis peopl like live citi technolog
evolv rapidli demograph famili chang mean fewer older peopl
famili care peopl today fewer children less like
marri live older gener lead declin support famili
transit high low mortal fertil accompani socioeconom
develop also chang lead caus diseas death demograph
epidemiologist describ shift part epidemiolog transit
characteris wane infecti acut diseas emerg import
chronic degen one
major epidemiolog trend see centuri rise chronic
degen diseas countri throughout world regardless incom level
project noncommunic diseas make one-half
pleas see import disclosur inform page report
korearest europebrazilrussiachinapharmergingti equiti research
medicin
progress chronic diseas
disabl sever disabl lessen
milder chronic diseas increas
diseas burden low-incom countri three-fourth middle-
incom countri infecti parasit diseas constitut
respect among noncommunic diseas alreadi account
burden low- middle- high-incom countri
peopl may live healthier longer live could also spend longer suffer
poor health debat among research answer broad
implic grow number older peopl around world
one way examin question look chang rate disabl
measur health function research think declin
preval disabl life expect increas term compress
morbid other see expans morbid increas preval
disabl life expect increas
yet other argu advanc medicin slow progress chronic
diseas disabl sever disabl lessen milder chronic diseas
increas instanc sever disabl usa fell
among older even life expect increas
less inform disabl middle- lower-incom countri
said number disabl peopl develop countri seem certain
increas number older peopl rise
age popul spend healthcar
popul age like influenc pattern healthcar spend
develop develop countri decad come develop countri
acut care institut long-term care servic wide avail
use medic care servic adult rise age per capita expenditur
healthcar rel high among older age group accordingli rise proport
older peopl place upward pressur overal healthcar spend
develop world although factor incom growth advanc
technolog capabl medicin gener play much larger role
mani elderli lose abil live independ limit mobil
frailti declin physic cognit function mani requir form
long-term care includ home nurs commun care assist live
residenti care long-stay hospit signific cost associ provid
support may need born famili societi less develop countri
establish afford long-term care infrastructur cost
may take form famili member withdraw employ school
care older rel developing-countri resid seek job citi
area older rel back home less access inform famili care
pleas see import disclosur inform page report
figur number peopl dementia
futur need long-term care servic formal inform larg
determin chang absolut number peopl oldest age group
coupl trend disabl rate given increas life expect
sheer numer growth older popul demograph momentum like
increas demand care growth could howev allevi declin
disabl among older peopl narrow gap femal male life
expect reduc widowhood could mean higher potenti suppli inform
care older spous
middl centuri un estim asia elderli popul reach
million share popul rise within
next decad asia becom world oldest region
world popul asia-pacif region account million older person
number set increas million billion
asian popul age quickli larg part
rapid fertil declin diminish rel size younger demograph
popul size younger cohort becom smaller group age
reach prime work age declin number new entrant working-
age categori see shift work popul toward elderli
consequ depend burden eas
middl centuri un
estim asia elderli popul
pleas see import disclosur inform page report
incom countrieslow incom countri figur growth popul age older india china
demograph transit toward age popul advanc
develop countri japan china newli industrialis economi
 hong kong korea singapor howev mani develop countri
region demograph path make transit much
although number elderli person increas nearli
million million share asia total popul constant
old-ag depend ratio mere howev asia
demograph landscap chang complet share elderli median
age old-ag depend ratio rise youngest base
popul stop expand median age rise year
old-ag depend ratio increas
although asia whole expect age within first half centuri
mark differ time speed among subregion east asia age fastest
western asia age slowest japan remain oldest countri
region nearli two everi five japanes year older rise old-
age depend caus japan total depend rate rise year
total depend rate bottom china hong kong korea singapor
countri remain far along age curv
develop countri like face similar challeng undergo
demograph transit howev popul age develop countri like
prove even difficult number reason estim asian develop
reveal typic countri old-ag depend ratio
per-capita gross nation product gnp project
suggest typic countri old-ag depend ratio
per-capita gnp less compar
asia whole expect age within
first half centuri
pleas see import disclosur inform page report
new diseas profil due age
develop asia new diseas profil due age
gaug econom impact shift diseas profil develop countri
estim loss econom output associ chronic diseas
low- middle-incom nation togeth account total
chronic diseas mortal develop world analysi focus
subset lead chronic diseas heart diseas stroke diabet
subset incur estim econom loss rang vietnam
ethiopia nearli china india
short-term project indic loss nearli doubl countri
prevent action taken potenti estim loss econom output
nation whole total
analysi global cancer trend economist intellig eiu estim
million new cancer case cost associ
new case least cost could escal silent
epidem cancer less well-off resource-scarc region peopl live longer
adopt diet lifestyl
eiu analysi estim less-develop countri account new
case larg global age incid cancer acceler
come decad project new cancer case rise million
reach million grow proport global total
less develop world almost half world new case occur asia
note follow figur cd communic diseas ncd non-communic
figur increas burden
figur increas burden
figur increas burden
mortal burden diseas
mortal burden diseas
mortal burden diseas
life expect asia
higher nation incom measur per capita gener associ
higher life expect birth larg region divid persist japan
longest life expect combin valu men women hong kong
australia singapor new zealand korea macao china exceed year
contrast numer countri asia-pacif combin life expect less
year papua new guinea cambodia myanmar india child born
expect live averag less year gener eastern asian
countri china japan korea higher life expect birth southeast
asian countri cambodia indonesia malaysia philippin thailand vietnam
southern asian countri india pakistan bangladesh
pleas see import disclosur inform page report
countri
bring epidemiolog transit
wherebi communic diseas
replac noncommunic diseas
cancer lead caus death
increas develop countri bring epidemiolog transit wherebi
communic diseas replac noncommunic diseas earli
death late death injuri respons death
noncommunic diseas cardiovascular syndrom cancer
common caus death respons two-third averag across
promin asian countri henc countri becom wealthier requir
differ focu healthcar system treat new seri afflict
cardiovascular diseas long lead caus death develop
countri asia-pacif becom increasingli preval recent decad
account one-third death cardiovascular diseas cover rang
ailment relat circulatori system includ ischaem heart diseas known
ihd heart attack cerebrovascular diseas stroke togeth ihd stroke
compris three quarter cardiovascular death asia
cardiovascular diseas affect younger age-group asia-pacif
counterpart oecd countri
cardiovascular mortal india year age- group twice usa
proport age person increas asia-pacif half world
cardiovascular burden could occur region
cancer lead caus death world-wide accord cancer claim
million live asia pacif death almost half cancer death
world-wide cardiovascular diseas age popul lead mani
case cancer asia alon expect five million annual cancer death
diabet one common noncommunic diseas global
chronic metabol diseas characteris high level glucos blood occur
either pancrea stop produc hormon insulin diabet
combin pancrea reduc abil produc insulin
alongsid bodi resist action diabet
figur increas burden
figur increas burden
figur increas burden
mortal burden diseas
mortal burden diseas
mortal burden diseas
peopl diabet greater risk develop seriou complic includ
cardiovascular diseas renal failur foot damag sight loss among
asian countri estim suggest million peopl adult
popul diabet
develop countri undergo epidemiolog transit rapid chang
lifestyl diet weight gain diseas diabet longer consid
diseas wealthi countri often limit resourc must cope
pleas see import disclosur inform page report
incom peak rel young age
drop worker late
doubl burden infecti diseas epidem diabet high preval
singapor hong kong macau indic might occur china rapidli
urbanis expand econom
asia age structur chang
chang age structur consequ demograph transit
asia birth death rate quit high popul grew rel slowli
howev death rate start declin lower mortal
particularli among infant children led steep increas number young
birth rate declin well consequ larg birth cohort
enter prime work age popul share
workforc swell time declin death rate reach older age result
persist increas life expect peopl like surviv
childhood year could also expect live well beyond retir old-ag
popul began show acceler growth
rate elderli popul asia increas howev
precipit declin fertil increas life expect
instanc project proport elderli japan korea singapor
instanc reach high level primarili low fertil rate lead
heavi fall working-ag adult popul
select asian economi labour incom peak rel young age
drop worker late labour incom quit high rel consumpt
china japan differ reason prc save rate high
thu incom high rel low consumpt age japan
seniority-bas wage system lead steadi increas incom rel late
work life
old-ag support system elderli asia
famili transfer old age much signific asia economi
estim avail fund life-cycl deficit
elderli taiwan one-third thailand slightli one-fifth china korea
philippin japan elderli provid much support children
grandchildren receiv
indonesia india distinct among asian countri net privat transfer
neg older rel european latin american countri
asia gener reli less public sector support elderli popul
korea taiwan net public transfer fund one-third life-cycl deficit
elderli
pleas see import disclosur inform page report
person save
sourc support asian economi
countri yet achiev
basic healthcar treat diseas
disabl among elderli
gener high prioriti
person save import sourc support asian economi except
china taiwan everi countri year old depend
save age increas import save declin replac
vari degre public transfer famili transfer gener asia elderli reli
much famili transfer age increas oldest age famili transfer
quit import fill gap life-cycl deficit one hand
declin save incom
fall save incom old common featur old-ag support
system asia declin save incom howev appear
consequ save among elderli rather old fewer asset either
bequest asset transfer descend
lower lifetim save due lower lifetim labour incom profil compar
younger cohort latter phenomenon link rapid growth incom
economi china korea taiwan china also special case
elderli could accumul asset young due past restrict
popul age place increas burden nation healthcar system
among world econom advanc countri includ japan healthcar
spend per capita four time higher peopl age older
rest popul whatev level econom develop popul age
present challeng financ deliv healthcar
peopl live longer grow demand care relat condit
vision impair dementia time mani countri asia still face
much higher preval childhood diseas acut respiratori infect
measl countri west also face continu need reproduct
health servic increas cost treat new re-emerg infecti
diseas hiv/aid drug-resist tuberculosi malaria
countri yet achiev basic healthcar treat diseas
disabl among elderli gener high prioriti countri major
challeng meet need expand elderli popul without sacrif
essenti servic everyon els mani countri spend healthcar
go year part result popul age
healthcar spend japan increas
increas south korea difficulti
countri asia expand elderli popul associ
healthcar need much lower level econom develop given high
cost involv adequ healthcar servic elderli may beyond reach
mani asian countri
pleas see import disclosur inform page report
aihw health expenditur databas aust bureau statist
asian govern take varieti approach healthcar financ
india individu household pay three-quart healthcar expens
pocket south korea out-of-pocket payment account one-half
healthcar expenditur japan univers health insur fund
individu employ signific govern subsidi premium
structur japan design gener cross-subsidi rich poor
young old thailand popul cover
type health insur
mani challeng face healthcar system countri similar
face pension scheme requir difficult balanc
need elderli willing taxpay support larg expens public
figur chang npat sensit decreas vs relev
pleas see import disclosur inform page report
npat sensit decreas vs relev currenc ann express us mcompanycodechang npat m/u proport npat npatansellann carerhc careshl figur care compar compani
pleas see import disclosur inform page report
compani namecodejef ratingcurr market cap market cappeg local cagrplasmacsl limitedcsl agbay biolog biolog product hold inc cbpo class agrf nordisk a/ class bnovob co devicescochlear limitedcoh scientif corporationbsx johnsonjnj plcmdt hold agsoon a/swdh apnearesm inc rmd paykel care corpor limitedfph philip phia radiolog fertilityson care limitedshl limitedhl ltd vrt ivf group ltdmvf diagnost ltd idx care group limitedaba laboratori inc class abio limitedcaj corpor america holdingslh diagnost incorporateddgx inc rdnt limitedrhc system inc cyh medicalrfmd care corporationthc inc class buh care bhd ihh dusit medic servic public co ltd bgh hospit enterpris limitedaph hospit public co ltd bh care group co siloam hospit reg-ssilo care india ltd forh care bhd kpj care ltdsig ltdapi group limitedebo comparablesansel limitedann liquid saai inc cah dwight co inc chd inc hon hold bhd hart corporationkmb rubber bhd kri companymmm benckis group plcrb hold agsem corp bhd sucb glove corpor bhd topg growth ev/ebitda price-to-earnings ansel limit ann au
base case pt base blend dcf
ev/ebitda normalis pe multipl assum
industri glove market growth healthcar glove
market growth along aud/usd
exchang rate aud/eur exchang rate
believ use protect glove link
growth global economi
upsid scenario pt base blend
dcf ev/ebitda normalis pe multipl assum
industri glove market growth healthcar
glove market growth along
aud/usd exchang rate
aud/eur exchang rate
downsid scenario pt base
blend dcf ev/ebitda normalis pe multipl
assum industri glove market growth
healthcar glove market growth
along aud/usd exchang rate
aud/eur exchang rate
age popul increas wealth howev
constant innov success acquisit
requir protect lower-pr substitut
input price foreign exchang volatil
ansel expect organ growth
busi ann abl achiev
would posit catalyst share price
pleas see import disclosur inform page report
base case pt base blend dcf
ev/ebitda normalis pe multipl assum
volum growth ci baha along
/u exchang rate
eur exchang rate continu believ
develop develop world market ci baha
under-penetrated
upsid scenario pt base blend
dcf ev/ebitda normalis pe multipl assum
volum growth ci baha
along /u exchang
rate /eur exchang rate
downsid scenario pt base
blend dcf ev/ebitda normalis pe multipl
assum volum growth ci baha
along /u
exchang rate /eur exchang rate
qualiti franchis establish track
record domin global market share
ci market said look expens
forward pe basi trade
histor mean
forward pe
believ elderli popul signific
untap market ci variou reason may
ascrib includ unwilling commit
evalu surgeri extens rehabilit coh
tri increas penetr us elderli
market roll campaign via integr
volunt advocaci also roll
campaign select countri
pleas see import disclosur inform page report
